Paper Review Records
All Paper Review Records
13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Affordability of CGRP-targeted therapies and physician support for reimbursement in Southeast Asia and East Asia: a cross-country analysis from the SEALANT study
Wanakorn Rattanawong; Akarin Hiransuthikul; Supakorn Chansaengpetch; Prakit Anukoolwittaya; Thanakit Pongpitakmetha; Sekh Thanprasertsuk; Nijanth Manohararaj; Wan Aliaa Wan Sulaiman; Gerard Saranza; John Luis Wee; Greg Dayrit; Irma Savitri Madjid; Devi Ariani Sudibyo; Pepi Budianto; Jr-Wei Wu; Appasone Phoumindr; Chananchida Sirilertmekasakul; Surat Tanprawate; Stewart J. TepperShow moreShow less
1. Department of Medicine, Faculty of Medicine, King Mongkut’s Institute of Technology Ladkrabang, Bangkok, Thailand; 2. Center for Natural and Artificial Intelligence (CNAI), Faculty of Medicine, King Mongkut’s Institute of Technology Ladkrabang, Bangkok, Thailand; 3. Comprehensive Headache and Orofacial Pain (CHOP) Service and Research Group, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 4. Department of Preventive and Social Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 5. Division of Neurology, Department of Medicine, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 6. Department of Pharmacology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 7. Department of Physiology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand; 8. Department of Neurology, National Neuroscience Institute, Singapore, Singapore; 9. Department of Neurology, Faculty of Medicine and Health Sciences, Universiti Putra Malaysia, Serdang, Malaysia; 10. Movement Disorders Service, Chong Hua Hospital & Vicente Sotto Memorial Medical Center, Cebu, Philippines; 11. Section of Neurology, Department of Internal Medicine, Chong Hua Hospital, Cebu, Philippines; 12. Department of Neurosciences, University of the Philippines- Philippine General Hospital, Manila, Philippines; 13. Departments of Anatomy & Internal Medicine, Cebu Institute of Medicine, Cebu, Philippines; 14. Department of Internal Medicine, Chong Hua Hospital, Cebu, Philippines; 15. Department of Neurosciences, St. Luke’s Medical Center College of Medicine -WHQM, Quezon City, Philippines; 16. Department of Neurology, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia; 17. Department of Neurology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; 18. Department of Neurology, Faculty of Medicine, Universitas Sebelas Maret, Jawa Tengah, Indonesia; 19. National Yang Ming Chiao Tung University, Taipei, Taiwan; 20. Department of Internal Medicine, Faculty of Medicine, University of Health Sciences, Vientiane Capital, Lao People’s Democratic Republic; 21. Division of Neurology, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 22. The Northern Neuroscience Center, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand; 23. The New England Institute for Neurology and Headache, Stamford, USAShow moreShow less
Migraine prevention with eptinezumab in real life – a retrospective Swiss cohort study
Vera A. Fankhauser; Franz Riederer; Reto M. Agosti; Bettina Anders; Philipp Balcerak; Lívia Granata; Jeremia Held; Christian P. Kamm; Antonella Palla; Athina Papadopoulou; Alexandre Pfister; Heiko Pohl; Jean‐Benoît Rossel; Philippe Ryvlin; Laura Maria Schmid; Kean Schönholzer; Adrian Scutelnic; Nedelina Slavova; Anamaria Ungureanu; Susanne Wegener; Chiara Zecca; Andreas R. Gantenbein; Christoph Josef SchankinShow moreShow less
1. University of Bern; 2. University Hospital of Bern; 3. University of Zurich; 4. GastroZentrum Hirslanden Zürich; 5. Bellevue Medical Group, Zurich, Switzerland; 6. Kantonsspital St. Gallen; 7. Schmerzzentrum Granata, Zurich, Switzerland; 8. Luzerner Kantonsspital; 9. University Hospital Zurich; 10. University of Basel; 11. University Hospital of Basel; 12. Centre Hospitalier Universitaire Vaudois; 13. Hôpital Orthopédique de la Suisse Romande; 14. Università della Svizzera italiana; 15. ZURZACH Care AGShow moreShow less
Pre-pregnancy migraine diagnosis, medication use, and spontaneous abortion: a prospective cohort study
Holly M. Crowe; Amelia K. Wesselink; Lauren A. Wise; Susan S. Jick; Kenneth J. Rothman; Ellen M. Mikkelsen; Henrik T. Sørensen; Elizabeth E. HatchShow moreShow less
1. Harvard T.H. Chan School of Public Health, Department of Epidemiology, Boston, USA; 2. Boston University School of Public Health, Department of Epidemiology, Boston, USA; 3. Aarhus University, Department of Clinical Epidemiology, Aarhus N, DenmarkShow moreShow less
Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre- and post- treatment with Erenumab
Todd J. Schwedt; Simona Nikolova; Gina Dumkrieger; Jing Li; Teresa Wu; Catherine D. ChongShow moreShow less
1. Department of Neurology, Mayo Clinic, Phoenix, USA; 2. School of Industrial and Systems Engineering, Georgia Tech, Atlanta, USA; 3. School of Computing, Informatics, Decision Systems Engineering, Arizona State University, Tempe, USAShow moreShow less
Migraine epidemiology and comorbidities in Southern Israel: a clinical database study in a universal health coverage setting
Ido Peles; Mohnnad Asla; Mariya Abayev; Michal Gordon; Victor Novack; Rinat Ribalov; Tamar Lengil; Ron Maor; Mayera Elizur; Gal IferganeShow moreShow less
1. Clinical Research Center, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; 2. Department of Neurology, Brain Medicine Division, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; 3. Internal Medicine Division, Soroka University Medical Center and the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel; 4. Teva Pharmaceuticals Industries Ltd, Tel Aviv, IsraelShow moreShow less
The premonitory phase of migraine is due to hypothalamic dysfunction: revisiting the evidence
Cedric Gollion; Roberto De Icco; David W. Dodick; Hakan AshinaShow moreShow less
1. Danish Headache Center, Department of Neurology, Rigshospitalet, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark; 2. Department of Neurology, University Hospital of Toulouse, Toulouse, France; 3. Department of Brain and Behavioral Science, University of Pavia, Pavia, Italy; 4. Headache Science & Neurorehabilitation Center, IRCCS Mondino Foundation, Pavia, Italy; 5. Department of Neurology, Mayo Clinic, Scottsdale, USA; 6. Department of Clinical Medicine, Faculty of Health Sciences, University of Copenhagen, Copenhagen, Denmark; 7. Department of Neurorehabilitation / Traumatic Brain Injury, Rigshospitalet, Copenhagen, Denmark; 8. Department of Anesthesia, Critical Care and Pain Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, USAShow moreShow less
FAQ
How long does JOURNAL OF HEADACHE AND PAIN take to review a manuscript?
As of 2026-11-19, CrushSCI has 13 complete review records for JOURNAL OF HEADACHE AND PAIN. The fastest paper went from submission to acceptance in 20 days (Longitudinal changes in functional connectivity and pain-induced brain activations in patients with migraine: a functional MRI study pre- and post- treatment with Erenumab, received 2022-09-17, accepted 2022-10-07); the slowest took 142 days. The average is 71 days and the median is 56 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
